SynthesisCanadian journal of gastroenterology & hepatology2017

The Efficacy and Safety of 12 Weeks of Sofosbuvir and Ledipasvir versus Sofosbuvir, Ledipasvir, and Ribavirin in Patients with Chronic Hepatitis C, Genotype 1, Who Have Cirrhosis and Have Failed Prior Therapy: A Systematic Review and Meta-Analysis.

William Stokes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.